Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
24%
OVERLAP
BY WEIGHT
35
# OF OVERLAPPING
HOLDINGS
WHCA.L
152
HOLDINGS
31%
ALSO IN EXV4.DE
EXV4.DE
60
HOLDINGS
78%
ALSO IN WHCA.L
SECTOR DRIFT (WHCA.L minus EXV4.DE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WHCA.L |
Weight in EXV4.DE |
Overlap | |
|---|---|---|---|---|
 |
NOVARTIS AG | 5.1% | 13.7% | 5.1% |
 |
ASTRAZENECA PLC | 3.7% | 13.8% | 3.7% |
|
ROCHE HOLDING AG-BR | 3.5% | 15.1% | 3.5% |
 |
NOVO NORDISK A/S-B | 2.5% | 9.3% | 2.5% |
|
ALCON, INC. | 1.4% | 2.0% | 1.4% |
WHCA.L Overweight Relative to EXV4.DE
 |
ELI LILLY & CO | 10.2% |
|
JOHNSON & JOHNSON | 4.8% |
|
ABBVIE INC | 4.5% |
|
UNITEDHEALTH GROUP INC | 3.4% |
|
MERCK & CO. INC. | 2.8% |
|
GILEAD SCIENCES INC | 2.7% |
|
VERTEX PHARMACEUTICALS INC | 2.1% |
|
THERMO FISHER SCIENTIFIC INC | 2.0% |
|
CENCORA INC | 1.9% |
|
ELEVANCE HEALTH INC | 1.9% |
WHCA.L Underweight Relative to EXV4.DE
|
ROCHE HOLDING AG-BR | -11.6% |
|
ASTRAZENECA PLC | -10.1% |
|
NOVARTIS AG | -8.5% |
|
NOVO NORDISK A/S-B | -6.8% |
 |
SANOFI-AVENTIS | -4.5% |
|
GSK PLC | -4.1% |
|
ESSILOR INTERNATIONAL | -3.8% |
 |
BAYER AG | -2.3% |
|
LONZA GROUP AG-REG | -2.3% |
|
HALEON PLC | -2.0% |